Suppr超能文献

支架间加和性。水蛭素c的P1变体与火鸡卵类黏蛋白第三结构域与丝氨酸蛋白酶的关联。

Interscaffolding additivity. Association of P1 variants of eglin c and of turkey ovomucoid third domain with serine proteinases.

作者信息

Qasim M A, Ganz P J, Saunders C W, Bateman K S, James M N, Laskowski M

机构信息

Department of Chemistry, Purdue University, West Lafayette, Indiana 47907, USA.

出版信息

Biochemistry. 1997 Feb 18;36(7):1598-607. doi: 10.1021/bi9620870.

Abstract

Standard mechanism protein inhibitors of serine proteinases share a common mechanism of interaction with their cognate enzymes. The P1 residue of the inhibitor interacts with the enzyme in a substrate-like manner. Its side chain becomes imbedded in the S1 cavity of the enzyme. The nature of P1, the primary specificity residue, greatly affects the strength and specificity of the enzyme inhibitor association. In canonical inhibitors, residues P4-P2'(P3'), where P1-P1' is the reactive site, share a common main chain conformation that does not change on complex formation. The remainder of the inhibitor's structure, the scaffolding, is not always common. Instead, there are at least 20 inhibitor families, each with a different scaffolding. In this paper, we ask whether the differences in standard free energy of association of enzyme-inhibitor complexes upon P1 mutations are independent of the nature of the scaffolding. We have already reported on 25 P1 variants of turkey ovomucoid third domain, a member of the Kazal inhibitor family, interacting with six different serine proteinases. Here, we report on seven different P1 variants of eglin c, a potato I family member, interacting with the same six serine proteinases under the same conditions. The differences in standard free energy on P1 mutations in the eglin c system agree very well, when P1 Pro is omitted. Complete agreement indicates that these P1 residues are interscaffolding additive. This is consistent with the superimposition of the high-resolution structures of eglin c and of turkey ovomucoid third domain with chymotrypsin. In both cases, the P1 Leu side chain is similarly oriented in almost indistinguishable specificity pockets of the enzyme.

摘要

丝氨酸蛋白酶的标准机制蛋白抑制剂与同源酶的相互作用机制相同。抑制剂的P1残基以类似底物的方式与酶相互作用。其侧链嵌入酶的S1腔中。P1作为主要特异性残基,其性质极大地影响酶与抑制剂结合的强度和特异性。在典型抑制剂中,P4 - P2'(P3')残基(其中P1 - P1'为反应位点)具有共同的主链构象,在形成复合物时不会改变。抑制剂结构的其余部分,即支架结构,并不总是相同的。相反,至少有20个抑制剂家族,每个家族都有不同的支架结构。在本文中,我们探讨了P1突变后酶 - 抑制剂复合物结合标准自由能的差异是否与支架结构的性质无关。我们已经报道了火鸡卵类粘蛋白第三结构域(Kazal抑制剂家族的一员)的25种P1变体与六种不同丝氨酸蛋白酶的相互作用。在此,我们报道了eglin c(马铃薯I家族成员)的七种不同P1变体在相同条件下与相同的六种丝氨酸蛋白酶的相互作用。当省略P1 Pro时,eglin c系统中P1突变的标准自由能差异非常吻合。完全吻合表明这些P1残基在不同支架结构之间具有加和性。这与eglin c和火鸡卵类粘蛋白第三结构域与胰凝乳蛋白酶的高分辨率结构叠加结果一致。在这两种情况下,P1 Leu侧链在酶的几乎难以区分的特异性口袋中具有相似的取向。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验